APLS Dec 2024 30.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:50AM EDT. Market open.
| Previous close | 17.40 |
| Open | 17.40 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 30.00 |
| Expiry date | 2024-12-20 |
| Day's range | 17.40 - 17.40 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
Simply Wall St.Apellis Pharmaceuticals First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Apellis Pharmaceuticals ( NASDAQ:APLS ) First Quarter 2024 Results Key Financial Results Revenue: US$172.3m (up 284...
- GuruFocus.com
Apellis Pharmaceuticals Inc (APLS) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...
Discover how Apellis Pharmaceuticals Inc navigated Q1 2024 with significant revenue increases and strategic advancements despite competitive challenges.
ZacksApellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
Apellis (APLS) reports first-quarter 2024 results, wherein earnings match the Zacks Consensus Estimate and revenues beat the same, driven by strong sales of Syfovre.
© 2024 Yahoo. All rights reserved.